Trial Profile
Adalimumab (Humira) in the treatment of psoriatic arthritis
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2006
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 21 Feb 2006 New trial record.